Benefit of Prolonged Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stent for Coronary Bifurcation Lesions: Results From the Coronary Bifurcation Stenting Registry II

BACKGROUND:Whether prolonged dual antiplatelet therapy (DAPT) improves clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesion is uncertain. METHODS AND RESULTS:We evaluated 2082 patients who were treated with drug-eluting stent for bifurcation lesions and were eve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Cardiovascular interventions 2018-07, Vol.11 (7), p.e005849-e005849
Hauptverfasser: Jang, Woo Jin, Ahn, Sung Gyun, Song, Young Bin, Choi, Seung-Hyuk, Chun, Woo Jung, Oh, Ju Hyeon, Cho, Sung Woo, Kim, Bum Sung, Yoon, Jung Han, Koo, Bon-Kwon, Yu, Cheol Woong, Jang, Yang Soo, Tahk, Seung-Jea, Kim, Hyo-Soo, Gwon, Hyeon-Cheol, Lee, Sung Yun, Hahn, Joo-Yong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUND:Whether prolonged dual antiplatelet therapy (DAPT) improves clinical outcomes after percutaneous coronary intervention for coronary bifurcation lesion is uncertain. METHODS AND RESULTS:We evaluated 2082 patients who were treated with drug-eluting stent for bifurcation lesions and were event free (no death, myocardial infarction [MI], cerebrovascular accident, stent thrombosis, or any revascularization) at 12 months after the index procedure. Patients were divided into 2 groupsDAPT ≥12-month group (n=1776) and DAPT
ISSN:1941-7640
1941-7632
DOI:10.1161/CIRCINTERVENTIONS.117.005849